Your browser doesn't support javascript.
loading
Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study.
Raitakari, Olli; Kivelä, Annukka; Pahkala, Katja; Rovio, Suvi; Mykkänen, Juha; Ahola-Olli, Ari; Loo, Britt-Marie; Lyytikäinen, Leo-Pekka; Lehtimäki, Terho; Kähönen, Mika; Juonala, Markus; Rönnemaa, Tapani; Lamina, Claudia; Kronenberg, Florian; Viikari, Jorma.
Afiliação
  • Raitakari O; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku,
  • Kivelä A; Novartis Finland Oy, Espoo, Finland.
  • Pahkala K; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Paavo Nurmi Centre and Unit for Health and Physical Activity, University of Turku, Turku,
  • Rovio S; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Mykkänen J; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Ahola-Olli A; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Loo BM; Joint Clinical Biochemistry Laboratory, Turku University Hospital, And University of Turku, Turku, Finland.
  • Lyytikäinen LP; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Lehtimäki T; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Kähönen M; Department of Clinical Physiology, Tampere University Hospital, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Juonala M; Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
  • Rönnemaa T; Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
  • Lamina C; Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Kronenberg F; Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Viikari J; Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
Atherosclerosis ; 356: 18-27, 2022 09.
Article em En | MEDLINE | ID: mdl-35961208

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2022 Tipo de documento: Article País de publicação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2022 Tipo de documento: Article País de publicação: Irlanda